Aminoglycoside resistance patterns of Serratia marcescens strains of clinical origin

Summary Aminoglycoside resistance patterns of 147 Serratia marcescens strains of clinical origin were studied. All strains analysed belonged to three different bacterial populations. The periods of study and the institutions the strains were isolated from correlated significantly with the resistance patterns shown by the strains. The most frequent resistance patterns found were the following: ACC (6')-I at the Hospital Infantil de México (Children's Hospital of México), and ANT (2″) +AAC(6′)-I at the Instituto Nacional de Pediatría (INPed or National Institute of Pediatrics) in Mexico City. Furthermore, the isolation frequency of aminoglycoside-sensitive strains decreased remarkably at the INPed over a 12-year period. These results suggest that there has been a selection of Serratia marcescens strains that are very resistant to aminoglycosides.

[1]  R. Coria-Jiménez,et al.  Biotyping of Serratia marcescens strains of clinical origin. , 1992, Revista latinoamericana de microbiologia.

[2]  P. Rather,et al.  Characterization of the chromosomal aac(6')-Ic gene from Serratia marcescens , 1992, Antimicrobial Agents and Chemotherapy.

[3]  S. Kocsi,et al.  Correlation between aminoglycoside resistance profiles and DNA hybridization of clinical isolates , 1991, Antimicrobial Agents and Chemotherapy.

[4]  V. R. Coria-Jiménez,et al.  Partial characterization of Serratia marcescens nosocomial strains. , 1991, Archivos de investigacion medica.

[5]  L. Elting,et al.  Serratia bacteremia: review of 118 cases. , 1989, Reviews of infectious diseases.

[6]  M. Rosenberg,et al.  Putative role of a 70 kDa outer-surface protein in promoting cell-surface hydrophobicity of Serratia marcescens RZ. , 1989, Journal of general microbiology.

[7]  H. H. Martin,et al.  Overproduced beta-lactamase and the outer-membrane barrier as resistance factors in Serratia marcescens highly resistant to beta-lactamase-stable beta-lactam antibiotics. , 1989, Journal of general microbiology.

[8]  S. Mitsuhashi,et al.  Quinolone resistance in clinical isolates of Serratia marcescens , 1989, Antimicrobial Agents and Chemotherapy.

[9]  V. Braun,et al.  Influence of growth temperature and lipopolysaccharide on hemolytic activity of Serratia marcescens , 1988, Journal of bacteriology.

[10]  C. Sanders,et al.  Inducible beta-lactamases: clinical and epidemiologic implications for use of newer cephalosporins. , 1988, Reviews of infectious diseases.

[11]  L. Gutmann,et al.  Some properties of Serratia marcescens, Salmonella paratyphi A, and Enterobacter cloacae with non-enzyme-dependent multiple resistance to beta-lactam antibiotics, aminoglycosides, and quinolones. , 1988, Reviews of infectious diseases.

[12]  V. Braun,et al.  Role of cell-bound hemolysin as a pathogenicity factor for Serratia infections , 1987, Infection and immunity.

[13]  W. Traub,et al.  Outer Membrane Protein Alterations in Serratia marcescens Resistant against Aminoglycoside and β-Lactam Antibiotics , 1987 .

[14]  D. Gerding,et al.  Frequency of aminoglycoside 6'-N-acetyltransferase among Serratia species during increased use of amikacin in the hospital , 1986, Antimicrobial Agents and Chemotherapy.

[15]  C. Watanakunakorn,et al.  Emergence of resistance to beta-lactams, aminoglycosides, and quinolones during combination therapy for infection due to Serratia marcescens. , 1986, The Journal of infectious diseases.

[16]  J. Sifuentes-Osornio,et al.  Analysis of epidemiologic markers of nosocomial Serratia marcescens isolates with special reference to the Grimont biotyping system , 1986, Journal of clinical microbiology.

[17]  H. Chung,et al.  Comparison of aminoglycoside resistance patterns in Japan, Formosa, and Korea, Chile, and the United States , 1985, Antimicrobial Agents and Chemotherapy.

[18]  C. Hardisson,et al.  [Development of resistance to aminoglycosides in hospital strains of Serratia]. , 1984, Pathologie-biologie.

[19]  C. Hardisson,et al.  Evolution de la résistance aux aminosides chez des souches hospitalières de Serratia , 1984 .

[20]  L. Gutmann,et al.  In vivo and in vitro emergence of simultaneous resistance to both beta-lactam and aminoglycoside antibiotics in a strain of Serratia marcescens. , 1983, Annales de microbiologie.

[21]  W. Traub,et al.  Plasmid-independent resistance of 'gray' colony variants of a strain of Serratia marcescens resistant to amikacin, cefotaxime and lamoxactam. , 1983, Chemotherapy.

[22]  Z. A. McGee,et al.  Loss of an aminoglycoside resistance plasmid by Serratia marcescens during treatment of meningitis with amikacin. , 1980, The Journal of infectious diseases.

[23]  V L Yu,et al.  Serratia marcescens: historical perspective and clinical review. , 1979 .

[24]  B. Davis,et al.  DETECTION OF SERRATIA OUTBREAKS IN HOSPITAL , 1976, The Lancet.